$PZG
Paramount Gold Nevada Corp.

2017 Q3 Form 10-Q Financial Statement

#000156459017022319 Filed on November 07, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2017 Q2 2016 Q3
Revenue $85.55K -$2.928K $5.306K
YoY Change 1512.29% -108.18% 2.0%
Cost Of Revenue $160.0K $140.0K $150.0K
YoY Change 6.67% 40.0% 87.5%
Gross Profit -$80.00K -$140.0K -$150.0K
YoY Change -46.67% 100.0% 87.5%
Gross Profit Margin -93.51% -2826.99%
Selling, General & Admin $300.0K $460.0K $500.0K
YoY Change -40.0% -866.67% 35.14%
% of Gross Profit
Research & Development $650.0K $2.380M $540.0K
YoY Change 20.37% 1486.67% 100.0%
% of Gross Profit
Depreciation & Amortization $938.00 $0.00 $1.102K
YoY Change -14.88% -28.72%
% of Gross Profit
Operating Expenses $1.170M $2.910M $1.270M
YoY Change -7.89% 1611.76% 57.12%
Operating Profit -$1.085M -$3.052M -$1.265M
YoY Change -14.26% 12.37% 57.48%
Interest Expense $0.00 $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.083M -$3.040M -$1.262M
YoY Change -14.2% 12.59% 57.35%
Income Tax $0.00 $0.00 -$3.220M
% Of Pretax Income
Net Earnings -$1.083M -$3.044M $1.953M
YoY Change -155.42% 12.54% -343.58%
Net Earnings / Revenue -1265.63% 36816.74%
Basic Earnings Per Share -$0.06 -$0.19 $0.13
Diluted Earnings Per Share -$0.06 -$0.19 $0.13
COMMON SHARES
Basic Shares Outstanding 17.78M 15.14M
Diluted Shares Outstanding 17.78M 15.42M

Balance Sheet

Concept 2017 Q3 2017 Q2 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $90.00K $1.910M $3.720M
YoY Change -97.58% -67.46% -55.07%
Cash & Equivalents $90.00K $1.911M $3.717M
Short-Term Investments
Other Short-Term Assets $198.0K $210.0K $550.0K
YoY Change -64.0% -62.63% 0.0%
Inventory
Prepaid Expenses
Receivables $100.0K $15.80K $20.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $929.1K $2.141M $4.280M
YoY Change -78.29% -71.25% -51.53%
LONG-TERM ASSETS
Property, Plant & Equipment $11.72K $12.66K $46.47M
YoY Change -99.97% -15.02% 65.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.090M $2.090M $2.350M
YoY Change -11.06% -11.06% -6.75%
Total Long-Term Assets $48.56M $48.56M $48.83M
YoY Change -0.55% 73.18% 59.73%
TOTAL ASSETS
Total Short-Term Assets $929.1K $2.141M $4.280M
Total Long-Term Assets $48.56M $48.56M $48.83M
Total Assets $49.49M $50.70M $53.11M
YoY Change -6.82% 42.88% 34.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $700.0K $870.0K $540.0K
YoY Change 29.63% 383.33% 350.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $920.0K $1.090M $920.0K
YoY Change 0.0% 94.68% 666.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.080M $1.040M $1.050M
YoY Change 2.86% 1.96% -21.05%
Total Long-Term Liabilities $1.080M $1.040M $1.050M
YoY Change 2.86% 1.96% -21.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $920.0K $1.090M $920.0K
Total Long-Term Liabilities $1.080M $1.040M $1.050M
Total Liabilities $2.000M $2.130M $1.980M
YoY Change 1.01% 34.99% 36.55%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $47.49M $48.57M $51.13M
YoY Change
Total Liabilities & Shareholders Equity $49.49M $50.70M $53.11M
YoY Change -6.81% 42.88% 34.8%

Cashflow Statement

Concept 2017 Q3 2017 Q2 2016 Q3
OPERATING ACTIVITIES
Net Income -$1.083M -$3.044M $1.953M
YoY Change -155.42% 12.54% -343.58%
Depreciation, Depletion And Amortization $938.00 $0.00 $1.102K
YoY Change -14.88% -28.72%
Cash From Operating Activities -$1.819M -$2.560M -$1.160M
YoY Change 56.83% 265.71% 16.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$1.000M
YoY Change -100.0% -100.0%
Cash From Investing Activities $0.00 $0.00 -$1.000M
YoY Change -100.0% -100.0% 9900.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -1.819M -2.560M -1.160M
Cash From Investing Activities 0.000 0.000 -1.000M
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash -1.819M -2.560M -2.160M
YoY Change -15.78% 113.33% 113.86%
FREE CASH FLOW
Cash From Operating Activities -$1.819M -$2.560M -$1.160M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$2.560M -$1.160M
YoY Change 265.71% 17.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 us-gaap Other Assets Current
OtherAssetsCurrent
197988
CY2016Q3 pzg Land Holding Costs
LandHoldingCosts
154611
CY2016Q3 us-gaap Professional Fees
ProfessionalFees
47991
CY2016Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
264843
CY2017Q2 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
216101
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11721
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
47489262
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
48566028
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49491609
CY2017Q3 us-gaap Revenues
Revenues
85548
CY2017Q3 us-gaap Exploration Expense Mining
ExplorationExpenseMining
646912
CY2016Q3 us-gaap Exploration Expense Mining
ExplorationExpenseMining
537371
CY2017Q3 pzg Land Holding Costs
LandHoldingCosts
161112
CY2017Q3 us-gaap Professional Fees
ProfessionalFees
18075
CY2017Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
142921
CY2017Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
20953
CY2016Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
45029
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
113602
CY2017Q3 us-gaap General Insurance Expense
GeneralInsuranceExpense
27938
CY2017Q3 us-gaap Depreciation
Depreciation
938
CY2017Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
37684
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
1170135
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1084587
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3818
CY2017Q3 pzg Interest And Service Charges
InterestAndServiceCharges
1950
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1082719
CY2016Q3 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-3215418
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15144322
CY2017 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
15202866
CY2017 pzg Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
3553156
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4339602
CY2017Q3 us-gaap Share Based Compensation
ShareBasedCompensation
5953
CY2016Q3 us-gaap Share Based Compensation
ShareBasedCompensation
67925
CY2017Q3 pzg Interest Earned On Reclamation Bond
InterestEarnedOnReclamationBond
3816
CY2016Q3 pzg Interest Earned On Reclamation Bond
InterestEarnedOnReclamationBond
3286
CY2016Q3 pzg Amortization Of Prepaid Insurance Expenses
AmortizationOfPrepaidInsuranceExpenses
12261
CY2017Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
80135
CY2017Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
197988
CY2017Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
329612
CY2017Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-169498
CY2017Q3 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1819193
CY2016Q3 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1159935
CY2016Q3 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
1001623
CY2017Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5953
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12659
CY2016Q3 us-gaap Other Income
OtherIncome
5306
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50700189
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17779954
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17779954
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15804
CY2017Q3 us-gaap Assets Current
AssetsCurrent
929124
CY2017Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
46460386
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17779954
CY2017Q3 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
216101
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17779954
CY2017Q3 us-gaap Other Income
OtherIncome
85548
CY2016Q3 us-gaap Revenues
Revenues
5306
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
142055
CY2016Q3 us-gaap General Insurance Expense
GeneralInsuranceExpense
42996
CY2016Q3 us-gaap Depreciation
Depreciation
1102
CY2016Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
34322
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
1270320
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1265014
CY2016Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3286
CY2016Q3 pzg Interest And Service Charges
InterestAndServiceCharges
194
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1261922
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-1082719
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
1953496
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17779954
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17779954
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15424838
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
33906187
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
243421
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1082719
CY2016Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15060
CY2016Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
358583
CY2016Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
363306
CY2016Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2157195
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5874258
CY2016Q3 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
4363
CY2016Q3 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-997260
CY2017Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1819193
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3717063
CY2017Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and cash equivalents and amounts receivable.&nbsp;&nbsp;The Company maintains cash and cash equivalents in accounts which may, at times, exceed federally insured limits.&nbsp;&nbsp;At September 30, 2017, the Company had nil balances in excess of federally insured limits.&nbsp;&nbsp;We deposit our cash with financial institutions which we believe have sufficient credit quality to minimize the risk of loss.</p></div>
CY2017Q3 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated interim financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant estimates made by management in the condensed consolidated interim financial statements include the adequacy of the Company&#8217;s asset retirement obligations, valuation of deferred tax asset, and valuation of mineral properties.</p></div>
CY2017Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1298718
CY2017Q3 us-gaap Insurance Recoveries
InsuranceRecoveries
80145
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
351236
CY2017Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1261034
CY2016Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1402039
CY2017 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
137288
CY2017 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
278293
CY2017Q3 pzg Concentration Of Credit Risk Uninsured Cash Amount
ConcentrationOfCreditRiskUninsuredCashAmount
0
CY2017Q3 pzg Cash Uninsured Amount Description
CashUninsuredAmountDescription
We deposit our cash with financial institutions which we believe have sufficient credit quality to minimize the risk of loss
CY2017Q3 us-gaap Nonmonetary Transaction Amount Of Barter Transaction
NonmonetaryTransactionAmountOfBarterTransaction
0
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
33334
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
33334
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.23
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.23
CY2017Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
9266
CY2017Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P11M13D
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
0
CY2017Q3 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
5403
CY2016Q3 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
5306
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
13800
CY2017Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
7043

Files In Submission

Name View Source Status
0001564590-17-022319-index-headers.html Edgar Link pending
0001564590-17-022319-index.html Edgar Link pending
0001564590-17-022319.txt Edgar Link pending
0001564590-17-022319-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g20171107191853168523.jpg Edgar Link pending
pzg-10q_20170930.htm Edgar Link pending
pzg-20170930.xml Edgar Link completed
pzg-20170930.xsd Edgar Link pending
pzg-20170930_cal.xml Edgar Link unprocessable
pzg-20170930_def.xml Edgar Link unprocessable
pzg-20170930_lab.xml Edgar Link unprocessable
pzg-20170930_pre.xml Edgar Link unprocessable
pzg-ex311_8.htm Edgar Link pending
pzg-ex312_9.htm Edgar Link pending
pzg-ex321_6.htm Edgar Link pending
pzg-ex322_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending